Galmed Pharmaceuticals (GLMD) Q3 2023 Earnings

22NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-1.5
-1.03
-0.57
-0.1

Details

Expected EPS
-0.3
Actual EPS
-0.24
Surprise EPS
0.06
Surprise Percent
+20%

Description

Galmed Pharmaceuticals (GLMD) has reported earnings of -0.24 per share for Q3 2023.

0 Comments

Share your thoughts